Merck & Co., Inc. Payments to Acquire Productive Assets
Merck & Co., Inc. (MRK) reported Payments to Acquire Productive Assets of $1.97 billion for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-07.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireProductiveAssets · last filed 2023-08-07
- Merck & Co., Inc. payments to acquire productive assets for the quarter ending 2023-06-30 was $965.00M, a 14.53% decline year-over-year.
- Merck & Co., Inc. payments to acquire productive assets for the quarter ending 2023-03-31 was $1.01B, a 2.34% increase year-over-year.
- Merck & Co., Inc. payments to acquire productive assets for the quarter ending 2022-12-31 was $1.15B, a 4.88% decline year-over-year.
- Merck & Co., Inc. payments to acquire productive assets for the quarter ending 2022-09-30 was $1.13B, a 3.92% decline year-over-year.
- Merck & Co., Inc. payments to acquire productive assets for fiscal 2022 was $4.39B, a 1.35% decline from fiscal 2021.
- Merck & Co., Inc. payments to acquire productive assets for fiscal 2021 was $4.45B, a 0.43% increase from fiscal 2020.
- Merck & Co., Inc. payments to acquire productive assets for fiscal 2020 was $4.43B, a 31.46% increase from fiscal 2019.
- Merck & Co., Inc. payments to acquire productive assets for fiscal 2019 was $3.37B, a 28.83% increase from fiscal 2018.
| Period end | Payments to Acquire Productive Assets 3 month | Payments to Acquire Productive Assets 3 month as first filed | Payments to Acquire Productive Assets 6 month | Payments to Acquire Productive Assets 6 month as first filed | Payments to Acquire Productive Assets 9 month | Payments to Acquire Productive Assets 9 month as first filed | Payments to Acquire Productive Assets 12 month | Payments to Acquire Productive Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-06-30 | $965.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $1.97B 10-Q · filed 2023-08-07 | $3.12B derived: sum of 3 quarters · filed 2023-08-07 | $4.25B derived: sum of 4 quarters · filed 2023-08-07 | ||||
| 2023-03-31 | $1.01B 10-Q · filed 2023-05-05 | $2.16B derived: sum of 2 quarters · filed 2023-05-05 | $3.28B derived: sum of 3 quarters · filed 2023-05-05 | $4.41B derived: sum of 4 quarters · filed 2023-08-07 | ||||
| 2022-12-31 | $1.15B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $2.27B derived: sum of 2 quarters · filed 2023-02-24 | $3.40B derived: sum of 3 quarters · filed 2023-08-07 | $4.39B 10-K · filed 2023-02-24 | ||||
| 2022-09-30 | $1.13B derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $2.25B derived: sum of 2 quarters · filed 2023-08-07 | $3.24B 10-Q · filed 2022-11-03 | $4.45B derived: sum of 4 quarters · filed 2023-08-07 | ||||
| 2022-06-30 | $1.13B derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $2.11B 10-Q · filed 2023-08-07 | $3.32B derived: sum of 3 quarters · filed 2023-08-07 | $4.49B derived: sum of 4 quarters · filed 2023-08-07 | ||||
| 2022-03-31 | $984.00M 10-Q · filed 2023-05-05 | $2.19B derived: sum of 2 quarters · filed 2023-05-05 | $3.36B derived: sum of 3 quarters · filed 2023-05-05 | $4.35B derived: sum of 4 quarters · filed 2023-05-05 | ||||
| 2021-12-31 | $1.21B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $2.38B derived: sum of 2 quarters · filed 2023-02-24 | $3.37B derived: sum of 3 quarters · filed 2023-02-24 | $4.45B 10-K · filed 2023-02-24 | ||||
| 2021-09-30 | $1.17B derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $2.16B derived: sum of 2 quarters · filed 2022-11-03 | $3.24B 10-Q · filed 2022-11-03 | $4.67B derived: sum of 4 quarters · filed 2023-02-24 | ||||
| 2021-06-30 | $986.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $2.07B 10-Q · filed 2022-08-05 | $3.50B derived: sum of 3 quarters · filed 2023-02-24 | $4.94B derived: sum of 4 quarters · filed 2023-02-24 | ||||
| 2021-03-31 | $1.08B 10-Q · filed 2022-05-05 | $1.13B 10-Q · filed 2021-05-05 | $2.51B derived: sum of 2 quarters · filed 2023-02-24 | $3.96B derived: sum of 3 quarters · filed 2023-02-24 | $4.53B derived: sum of 4 quarters · filed 2023-02-24 | |||
| 2020-12-31 | $1.43B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $2.88B derived: sum of 2 quarters · filed 2023-02-24 | $3.44B derived: sum of 3 quarters · filed 2023-02-24 | $4.43B 10-K · filed 2023-02-24 | $4.68B 10-K · filed 2021-02-25 | |||
| 2020-09-30 | $1.45B derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $2.01B derived: sum of 2 quarters · filed 2021-11-05 | $3.00B 10-Q · filed 2021-11-05 | $3.17B 10-Q · filed 2020-11-05 | $4.03B derived: sum of 4 quarters · filed 2022-02-25 | |||
| 2020-06-30 | $567.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $1.55B 10-Q · filed 2021-08-09 | $1.65B 10-Q · filed 2020-08-05 | $2.59B derived: sum of 3 quarters · filed 2022-02-25 | $3.54B derived: sum of 4 quarters · filed 2022-02-25 | |||
| 2020-03-31 | $986.00M 10-Q · filed 2021-05-05 | $2.02B derived: sum of 2 quarters · filed 2022-02-25 | $2.98B derived: sum of 3 quarters · filed 2022-02-25 | $3.76B derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2019-12-31 | $1.03B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $1.99B derived: sum of 2 quarters · filed 2022-02-25 | $2.77B derived: sum of 3 quarters · filed 2022-02-25 | $3.37B 10-K · filed 2022-02-25 | $3.47B 10-K · filed 2020-02-26 | |||
| 2019-09-30 | $959.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $1.74B derived: sum of 2 quarters · filed 2020-11-05 | $2.34B 10-Q · filed 2020-11-05 | $3.27B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | $782.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $1.38B 10-Q · filed 2020-08-05 | $2.31B derived: sum of 3 quarters · filed 2021-02-25 | $2.96B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | $595.00M 10-Q · filed 2020-05-06 | $1.52B derived: sum of 2 quarters · filed 2021-02-25 | $2.18B derived: sum of 3 quarters · filed 2021-02-25 | $2.76B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | $929.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $1.58B derived: sum of 2 quarters · filed 2021-02-25 | $2.17B derived: sum of 3 quarters · filed 2021-02-25 | $2.62B 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | $653.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $1.24B derived: sum of 2 quarters · filed 2019-11-05 | $1.69B 10-Q · filed 2019-11-05 | $2.40B derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2018-06-30 | $583.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $1.03B 10-Q · filed 2019-08-06 | $1.75B derived: sum of 3 quarters · filed 2020-02-26 | $2.19B derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2018-03-31 | $450.00M 10-Q · filed 2019-05-08 | $1.17B derived: sum of 2 quarters · filed 2020-02-26 | $1.61B derived: sum of 3 quarters · filed 2020-02-26 | $2.00B derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2017-12-31 | $715.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $1.16B derived: sum of 2 quarters · filed 2020-02-26 | $1.55B derived: sum of 3 quarters · filed 2020-02-26 | $1.89B 10-K · filed 2020-02-26 | ||||
| 2017-09-30 | $441.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $834.00M derived: sum of 2 quarters · filed 2018-11-06 | $1.17B 10-Q · filed 2018-11-06 | $1.72B derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-06-30 | $393.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $732.00M 10-Q · filed 2018-08-07 | $1.28B derived: sum of 3 quarters · filed 2019-02-27 | $1.69B derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-03-31 | $339.00M 10-Q · filed 2018-05-08 | $890.00M derived: sum of 2 quarters · filed 2019-02-27 | $1.30B derived: sum of 3 quarters · filed 2019-02-27 | $1.67B derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2016-12-31 | $551.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $960.00M derived: sum of 2 quarters · filed 2019-02-27 | $1.33B derived: sum of 3 quarters · filed 2019-02-27 | $1.61B 10-K · filed 2019-02-27 | ||||
| 2016-09-30 | $409.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $784.00M derived: sum of 2 quarters · filed 2017-11-07 | $1.06B 10-Q · filed 2017-11-07 | $1.56B derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-06-30 | $375.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $654.00M 10-Q · filed 2017-08-08 | $1.15B derived: sum of 3 quarters · filed 2018-02-27 | $1.46B derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-03-31 | $279.00M 10-Q · filed 2017-05-09 | $772.00M derived: sum of 2 quarters · filed 2018-02-27 | $1.09B derived: sum of 3 quarters · filed 2018-02-27 | $1.36B derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | $493.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $809.00M derived: sum of 2 quarters · filed 2018-02-27 | $1.08B derived: sum of 3 quarters · filed 2018-02-27 | $1.28B 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | $316.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $587.00M derived: sum of 2 quarters · filed 2016-11-07 | $790.00M 10-Q · filed 2016-11-07 | $1.28B derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-06-30 | $271.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $474.00M 10-Q · filed 2016-08-08 | $964.00M derived: sum of 3 quarters · filed 2017-02-28 | $1.28B derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-03-31 | $203.00M 10-Q · filed 2016-05-09 | $693.00M derived: sum of 2 quarters · filed 2017-02-28 | $1.01B derived: sum of 3 quarters · filed 2017-02-28 | $1.31B derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2014-12-31 | $490.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $810.00M derived: sum of 2 quarters · filed 2017-02-28 | $1.11B derived: sum of 3 quarters · filed 2017-02-28 | $1.32B 10-K · filed 2017-02-28 | ||||
| 2014-09-30 | $320.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $622.00M derived: sum of 2 quarters · filed 2015-11-05 | $827.00M 10-Q · filed 2015-11-05 | $1.26B derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-06-30 | $302.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $507.00M 10-Q · filed 2015-08-06 | $936.00M derived: sum of 3 quarters · filed 2016-02-26 | $1.29B derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-03-31 | $205.00M 10-Q · filed 2015-05-07 | $634.00M derived: sum of 2 quarters · filed 2016-02-26 | $989.00M derived: sum of 3 quarters · filed 2016-02-26 | $1.40B derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2013-12-31 | $429.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $784.00M derived: sum of 2 quarters · filed 2016-02-26 | $1.20B derived: sum of 3 quarters · filed 2016-02-26 | $1.55B 10-K · filed 2016-02-26 | ||||
| 2013-09-30 | $355.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $768.00M derived: sum of 2 quarters · filed 2014-11-10 | $1.12B 10-Q · filed 2014-11-10 | $1.90B derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-06-30 | $413.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $764.00M 10-Q · filed 2014-08-07 | $1.54B derived: sum of 3 quarters · filed 2015-02-27 | $1.96B derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-03-31 | $351.00M 10-Q · filed 2014-05-08 | $1.13B derived: sum of 2 quarters · filed 2015-02-27 | $1.54B derived: sum of 3 quarters · filed 2015-02-27 | $1.97B derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2012-12-31 | $778.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $1.19B derived: sum of 2 quarters · filed 2015-02-27 | $1.62B derived: sum of 3 quarters · filed 2015-02-27 | $1.95B 10-K · filed 2015-02-27 | ||||
| 2012-09-30 | $414.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $845.00M derived: sum of 2 quarters · filed 2013-11-07 | $1.18B 10-Q · filed 2013-11-07 | $1.78B derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2012-06-30 | $431.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $762.00M 10-Q · filed 2013-08-07 | $1.36B derived: sum of 3 quarters · filed 2014-02-27 | $1.80B derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2012-03-31 | $331.00M 10-Q · filed 2013-05-09 | $934.00M derived: sum of 2 quarters · filed 2014-02-27 | $1.36B derived: sum of 3 quarters · filed 2014-02-27 | $1.73B derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2011-12-31 | $603.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $1.03B derived: sum of 2 quarters · filed 2014-02-27 | $1.40B derived: sum of 3 quarters · filed 2014-02-27 | $1.72B 10-K · filed 2014-02-27 | ||||
| 2011-09-30 | $431.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $796.00M derived: sum of 2 quarters · filed 2012-11-09 | $1.12B 10-Q · filed 2012-11-09 | $1.78B derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-06-30 | $365.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $689.00M 10-Q · filed 2012-08-07 | $1.35B derived: sum of 3 quarters · filed 2013-02-28 | $1.69B derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-03-31 | $324.00M 10-Q · filed 2012-05-08 | $984.00M derived: sum of 2 quarters · filed 2013-02-28 | $1.32B derived: sum of 3 quarters · filed 2013-02-28 | $1.66B derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2010-12-31 | $660.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $998.00M derived: sum of 2 quarters · filed 2013-02-28 | $1.33B derived: sum of 3 quarters · filed 2013-02-28 | $1.68B 10-K · filed 2013-02-28 | ||||
| 2010-09-30 | $338.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $675.00M derived: sum of 2 quarters · filed 2011-11-08 | $1.02B 10-Q · filed 2011-11-08 | $1.02B 10-Q · filed 2010-11-08 | $1.58B derived: sum of 4 quarters · filed 2012-02-28 | |||
| 2010-06-30 | $337.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-08 | $680.00M 10-Q · filed 2011-08-08 | $679.80M 10-Q · filed 2010-08-06 | $1.24B derived: sum of 3 quarters · filed 2012-02-28 | $1.54B derived: sum of 4 quarters · filed 2012-02-28 | |||
| 2010-03-31 | $343.00M 10-Q · filed 2011-05-09 | $342.80M 10-Q · filed 2010-05-07 | $900.40M derived: sum of 2 quarters · filed 2012-02-28 | $1.20B derived: sum of 3 quarters · filed 2012-02-28 | $1.57B derived: sum of 4 quarters · filed 2012-02-28 | |||
| 2009-12-31 | $557.40M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $860.70M derived: sum of 2 quarters · filed 2012-02-28 | $1.23B derived: sum of 3 quarters · filed 2012-02-28 | $1.46B 10-K · filed 2012-02-28 | $1.46B 10-K · filed 2010-03-01 | |||
| 2009-09-30 | $303.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | $668.50M derived: sum of 2 quarters · filed 2010-11-08 | $903.60M 10-Q · filed 2010-11-08 | |||||
| 2009-06-30 | $365.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-06 | $600.30M 10-Q · filed 2010-08-06 | ||||||
| 2009-03-31 | $235.10M 10-Q · filed 2010-05-07 | |||||||
| 2008-12-31 | $1.30B 10-K · filed 2011-02-28 | $1.30B 10-K · filed 2010-03-01 | ||||||
| 2007-12-31 | $1.01B 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |